Sanofi and GSK delay Covid-19 vaccine, marking setback for global fight ...Qatar

Gulf Times - News
Sanofi and GSK delay Covid-19 vaccine, marking setback for global fight
* Phase I/II results show low immune response in older adults * Setback to global efforts to develop multiple vaccines * New study expected next year using improved formulation * Hopes for regulatory submission in second half of 2021 Sanofi and GlaxoSmithKline said clinical trials of their Covid-19 vaccine showed an insufficient immune response in older people, delaying its launch to late next year and marking a setback in the global fight against the pandemic. The announcement on Friday, which highlighted the challenges of developing shots at record speed, hinders efforts to develop the multiple options that experts say the world needs to counter a disease that has killed over 1.5 mil

Hence then, the article about sanofi and gsk delay covid 19 vaccine marking setback for global fight was published today ( ) and is available on Gulf Times ( Qatar ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sanofi and GSK delay Covid-19 vaccine, marking setback for global fight )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News